Breast Cancer Research

official impact factor 5.79

Review

Are we HER-ting for innovation in neoadjuvant breast cancer trial design?

Natasa Snoj, Philippe L Bedard, Evandro de Azambuja, Fatima Cardoso and Martine Piccart*

Breast Cancer Research 2009, 11:201 doi:10.1186/bcr2209

No comments have yet been made on this article.

Post a comment